Literature DB >> 23865410

Perioperative antibiotic use of dermatologic surgeons in 2012.

Yoon-Soo C Bae-Harboe1, Christine A Liang.   

Abstract

BACKGROUND: Recommendations for antibiotic prophylaxis in dermatologic surgery have been established, but there is variability in perioperative antibiotic use of dermatologists. Authoritative guidelines have shifted away from routine use of antibiotic prophylaxis because there is no conclusive evidence that antibiotic use reduces risk of infective endocarditis or prosthetic joint infection.
OBJECTIVE: To determine current practices of perioperative antibiotic use of Mohs-trained surgeons and to compare patterns of use with updated administration guidelines. METHODS AND MATERIALS: A survey was sent to American College of Mohs Surgery members in 2012. The main outcome measures were survey responses relating to demographic characteristics, experience with postoperative infection, familiarity with antibiotic guidelines, perioperative antibiotic practices, attitudes regarding antibiotic use, and antibiotic selection.
RESULTS: Most survey respondents are familiar with the Antibiotic Prophylaxis in Dermatologic Surgery Advisory Statement 2008, but respondents give antibiotics for more indications than are recommended. Although not recommended, a high percentage reported giving antibiotics to patients at high risk of infective endocarditis or joint infection even when surgery does not breach oral mucosa or involve infected skin.
CONCLUSION: Dermatologic surgeons overuse perioperative antibiotics for prevention of surgical site infection, infective endocarditis, and prosthetic joint infection based on current recommendations.
© 2013 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23865410     DOI: 10.1111/dsu.12272

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  6 in total

1.  [Antibiotic prophylaxis in dermatologic and soft tissue surgery].

Authors:  T Schulze; M Napp; S Maier
Journal:  Hautarzt       Date:  2014-01       Impact factor: 0.751

2.  [Significance and prevention of post-operative wound complications].

Authors:  M Napp; D Gümbel; J Lange; P Hinz; G Daeschlein; A Ekkernkamp
Journal:  Hautarzt       Date:  2014-01       Impact factor: 0.751

3.  Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 3: Current Perspectives on Skin and Soft Tissue Infections with Emphasis on Methicillin-resistant Staphylococcus aureus, Commonly Encountered Scenarios when Antibiotic Use May Not Be Needed, and Concluding Remarks on Rational Use of Antibiotics in Dermatology.

Authors:  James Q Del Rosso; Ted Rosen; Diane Thiboutot; Guy F Webster; Richard L Gallo; James J Leyden; Clay Walker; George Zhanel; Lawrence Eichenfield
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

4.  Use of Antibiotics for Dermatologic Procedures From 2008 to 2016.

Authors:  John S Barbieri; Jeremy R Etzkorn; David J Margolis
Journal:  JAMA Dermatol       Date:  2019-04-01       Impact factor: 10.282

5.  Trends in Oral Antibiotic Prescription in Dermatology, 2008 to 2016.

Authors:  John S Barbieri; Ketaki Bhate; Kathleen P Hartnett; Katherine E Fleming-Dutra; David J Margolis
Journal:  JAMA Dermatol       Date:  2019-03-01       Impact factor: 10.282

Review 6.  Using Implementation Science to Optimize the Uptake of Evidence-Based Medicine into Dermatology Practice.

Authors:  Sepideh Ashrafzadeh; Joshua P Metlay; Niteesh K Choudhry; Karen M Emmons; Maryam M Asgari
Journal:  J Invest Dermatol       Date:  2019-12-18       Impact factor: 8.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.